Home
>
National Drug Code (NDC)
>
Altoprev
Altoprev - 59630-629-30 - (lovastatin)
Drug Information of Altoprev
| Product NDC: | 59630-629 |
| Proprietary Name: | Altoprev |
| Non Proprietary Name: | lovastatin |
| Active Ingredient(s): | 40 mg/1 & nbsp; lovastatin |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Altoprev
| Product NDC: | 59630-629 |
| Labeler Name: | Shionogi Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021316 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020626 |
Package Information of Altoprev
| Package NDC: | 59630-629-30 |
| Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59630-629-30) |
NDC Information of Altoprev
| NDC Code | 59630-629-30 |
| Proprietary Name | Altoprev |
| Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (59630-629-30) |
| Product NDC | 59630-629 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | lovastatin |
| Dosage Form Name | TABLET, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20020626 |
| Marketing Category Name | NDA |
| Labeler Name | Shionogi Inc. |
| Substance Name | LOVASTATIN |
| Strength Number | 40 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |
